CRL
Price
$135.63
Change
-$2.07 (-1.50%)
Updated
May 30 closing price
Capitalization
13.96B
59 days until earnings call
OPK
Price
$1.36
Change
-$0.00 (-0.00%)
Updated
May 30 closing price
Capitalization
920.03M
60 days until earnings call
Interact to see
Advertisement

CRL vs OPK

Header iconCRL vs OPK Comparison
Open Charts CRL vs OPKBanner chart's image
Charles River Laboratories International
Price$135.63
Change-$2.07 (-1.50%)
Volume$807.12K
Capitalization13.96B
OPKO Health
Price$1.36
Change-$0.00 (-0.00%)
Volume$3.97M
Capitalization920.03M
CRL vs OPK Comparison Chart
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. OPK commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Buy and OPK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (CRL: $135.63 vs. OPK: $1.36)
Brand notoriety: CRL and OPK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 45% vs. OPK: 114%
Market capitalization -- CRL: $13.96B vs. OPK: $920.03M
CRL [@Medical Specialties] is valued at $13.96B. OPK’s [@Medical Specialties] market capitalization is $920.03M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileOPK’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • OPK’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 5 TA indicator(s) are bullish while OPK’s TA Score has 5 bullish TA indicator(s).

  • CRL’s TA Score: 5 bullish, 4 bearish.
  • OPK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OPK is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а -0.80% price change this week, while OPK (@Medical Specialties) price change was +7.94% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.06%. For the same industry, the average monthly price growth was +2.33%, and the average quarterly price growth was -2.29%.

Reported Earning Dates

CRL is expected to report earnings on Jul 30, 2025.

OPK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.06% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than OPK($920M). CRL has higher P/E ratio than OPK: CRL (29.15) vs OPK (26.11). OPK YTD gains are higher at: -7.483 vs. CRL (-26.528). CRL has higher annual earnings (EBITDA): 1.03B vs. OPK (-65.52M). CRL has more cash in the bank: 277M vs. OPK (95.9M). OPK has less debt than CRL: OPK (327M) vs CRL (3.07B). CRL has higher revenues than OPK: CRL (4.13B) vs OPK (863M).
CRLOPKCRL / OPK
Capitalization14B920M1,522%
EBITDA1.03B-65.52M-1,575%
Gain YTD-26.528-7.483355%
P/E Ratio29.1526.11112%
Revenue4.13B863M478%
Total Cash277M95.9M289%
Total Debt3.07B327M938%
FUNDAMENTALS RATINGS
CRL vs OPK: Fundamental Ratings
CRL
OPK
OUTLOOK RATING
1..100
3812
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9090
PRICE GROWTH RATING
1..100
6277
P/E GROWTH RATING
1..100
198
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPK's Valuation (67) in the Biotechnology industry is in the same range as CRL (96) in the Miscellaneous Commercial Services industry. This means that OPK’s stock grew similarly to CRL’s over the last 12 months.

OPK's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRL (100) in the Miscellaneous Commercial Services industry. This means that OPK’s stock grew similarly to CRL’s over the last 12 months.

OPK's SMR Rating (90) in the Biotechnology industry is in the same range as CRL (90) in the Miscellaneous Commercial Services industry. This means that OPK’s stock grew similarly to CRL’s over the last 12 months.

CRL's Price Growth Rating (62) in the Miscellaneous Commercial Services industry is in the same range as OPK (77) in the Biotechnology industry. This means that CRL’s stock grew similarly to OPK’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is significantly better than the same rating for OPK (98) in the Biotechnology industry. This means that CRL’s stock grew significantly faster than OPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLOPK
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
68%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 17 days ago
69%
Bearish Trend 9 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALOIX34.000.09
+0.27%
Virtus International S/C Instl
DDVRX13.520.03
+0.22%
Macquarie Value R
USPRX73.970.03
+0.04%
Victory 500 Index Reward
HNIDX13.82-0.02
-0.14%
Harbor Diversified Intl All Cp Retire
PVCMX12.28-0.02
-0.16%
Palm Valley Capital Investor

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-1.50%
IQV - CRL
73%
Closely correlated
-0.49%
RVTY - CRL
61%
Loosely correlated
-1.62%
NOTV - CRL
58%
Loosely correlated
-7.14%
MEDP - CRL
57%
Loosely correlated
-0.72%
RGEN - CRL
56%
Loosely correlated
-3.47%
More

OPK and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPK has been loosely correlated with ICUI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if OPK jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPK
1D Price
Change %
OPK100%
N/A
ICUI - OPK
38%
Loosely correlated
+0.32%
XAIR - OPK
35%
Loosely correlated
-4.00%
CLPT - OPK
34%
Loosely correlated
-1.34%
CRL - OPK
33%
Loosely correlated
-1.50%
IQV - OPK
33%
Poorly correlated
-0.49%
More